Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MMT
12201
Aberdeen Multi-Market Income Fund
MMT
$236M
| $70.6K | ﹤0.01% |
15,291
-3,004
| -16% | -$14K |
2025 Q4
1 quarter
|
|
12202
CALL
Rekor Systems
REKR
$51.1M
| $70.5K | ﹤0.01% |
86,000
+56,100
| +188% | +$60.1K |
2020 Q4
21 quarters
|
|
12203
Loop Industries
LOOP
$21.7M
| $70.5K | ﹤0.01% |
49,275
-7,405
| -13% | -$9.28K |
2025 Q1
4 quarters
|
|
|
FOCL
12204
PUT
EDAP TMS S.A.
FOCL
$198M
| $70.3K | ﹤0.01% |
+18,900
| New | +$77.9K |
2026 Q1
0 quarters
|
|
|
BCAB
12205
DELISTED
BIOATLA INC
BCAB
| $70.1K | ﹤0.01% |
+8,714
| New | +$102K |
2026 Q1
0 quarters
|
|
12206
CALL
Grid Dynamics Holdings
GDYN
$651M
| $70.1K | ﹤0.01% |
12,300
-17,300
| -58% | -$127K |
2025 Q4
1 quarter
|
|
12207
PUT
Neumora Therapeutics
NMRA
$93.9M
| $70K | ﹤0.01% |
35,900
+23,500
| +190% | +$60.9K |
2023 Q4
9 quarters
|
|
|
NNEX
12208
CALL
DELISTED
Tradr 2X Long NNE Daily ETF
NNEX
| $70K | ﹤0.01% |
+12,300
| New | +$141K |
2026 Q1
0 quarters
|
|
12209
PUT
AMC Global Media
AMCX
$460M
| $69.9K | ﹤0.01% |
10,300
-3,500
| -25% | -$27.2K |
2019 Q4
25 quarters
|
|
12210
CALL
Quantum-Si Incorporated
QSI
$339M
| $69.8K | ﹤0.01% |
90,200
-170,800
| -65% | -$177K |
2021 Q1
20 quarters
|
|
|
YDKG
12211
Yueda Digital Holding
YDKG
$5.14M
| $69.5K | ﹤0.01% |
+72,152
| New | +$66.6K |
2026 Q1
0 quarters
|
|
12212
CALL
James River Group Holdings
JRVR
$161M
| $69.3K | ﹤0.01% |
+11,000
| New | +$72.3K |
2026 Q1
0 quarters
|
|
12213
PUT
Health Catalyst
HCAT
$132M
| $69K | ﹤0.01% |
+54,300
| New | +$102K |
2026 Q1
0 quarters
|
|
12214
PUT
Opko Health
OPK
$1.16B
| $68.9K | ﹤0.01% |
60,400
-1,000
| -2% | -$1.23K |
2013 Q2
51 quarters
|
|
|
HDSN
12215
CALL
Hudson Technologies
HDSN
$220M
| $68.8K | ﹤0.01% |
+11,700
| New | +$80.2K |
2026 Q1
0 quarters
|
|
|
DHY
12216
UBS Asset Management High Yield Credit Fund
DHY
$222M
| $68.8K | ﹤0.01% |
3,621
+1,626
| +82% | +$31.8K |
2025 Q4
1 quarter
|
|
|
ILPT
12217
CALL
Industrial Logistics Properties Trust
ILPT
$473M
| $68.7K | ﹤0.01% |
+12,100
| New | +$70.4K |
2026 Q1
0 quarters
|
|
12218
CALL
Castor Maritime
CTRM
$19.3M
| $68.6K | ﹤0.01% |
37,100
-80,600
| -68% | -$172K |
2025 Q4
1 quarter
|
|
12219
PUT
Personalis
PSNL
$1.74B
| $68.2K | ﹤0.01% |
10,700
-8,300
| -44% | -$70.1K |
2024 Q3
6 quarters
|
|
12220
CALL
Alector
ALEC
$202M
| $68.2K | ﹤0.01% |
31,700
-1,200
| -4% | -$2.41K |
2020 Q3
22 quarters
|
|
|
BRNS
12221
DELISTED
Barinthus Biotherapeutics
BRNS
| $68.1K | ﹤0.01% |
118,996
+197
| +0.2% | +$130 |
2025 Q4
1 quarter
|
|
12222
CALL
GrowGeneration
GRWG
$92.5M
| $68K | ﹤0.01% |
61,800
+27,600
| +81% | +$34.4K |
2020 Q2
23 quarters
|
|
12223
CALL
Epsilon Energy
EPSN
$174M
| $67.8K | ﹤0.01% |
+11,000
| New | +$56.1K |
2026 Q1
0 quarters
|
|
|
HELP
12224
CALL
Helus Pharma Inc. Common Stock
HELP
$855M
| $67.7K | ﹤0.01% |
14,100
-29,400
| -68% | -$190K |
2024 Q4
5 quarters
|
|
12225
Xcel Brands
XELB
$4.31M
| $67.4K | ﹤0.01% |
+43,513
| New | +$66.7K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.